Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (611-620 of 743) with videos related to

Pageof 75
Sort By:
BMC Biotechnology|October 14, 2003
Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletionsFrederique Ponchel, Carmel Toomes, Kieran Bransfield, et al.
Human Genetics|April 6, 2002
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer riskBao-li Chang, Siqun L Zheng, Gregory A Hawkins, et al.
Cancer Research|March 26, 2002
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibilityBao-li Chang, Siqun L Zheng, Gregory A Hawkins, et al.
Clinical and Experimental Immunology|September 27, 2016
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4<sup>+</sup> T cells partly via transforming growth factor-β1A E Anderson, D J Swan, O Y Wong, et al.
Cancer Research|November 14, 1997
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1H Grönberg, J Xu, J R Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
American Journal of Human Genetics|December 10, 2002
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskJianfeng Xu, S Lilly Zheng, Akira Komiya, et al.
Pageof 75

Showing results (611-620 of 743) with videos related to

Sort By:
Pageof 75
BMC Biotechnology|October 14, 2003
Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletionsFrederique Ponchel, Carmel Toomes, Kieran Bransfield, et al.
Human Genetics|April 6, 2002
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer riskBao-li Chang, Siqun L Zheng, Gregory A Hawkins, et al.
Cancer Research|March 26, 2002
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibilityBao-li Chang, Siqun L Zheng, Gregory A Hawkins, et al.
Clinical and Experimental Immunology|September 27, 2016
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4<sup>+</sup> T cells partly via transforming growth factor-β1A E Anderson, D J Swan, O Y Wong, et al.
Cancer Research|November 14, 1997
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1H Grönberg, J Xu, J R Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
American Journal of Human Genetics|December 10, 2002
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskJianfeng Xu, S Lilly Zheng, Akira Komiya, et al.
Pageof 75